Docosanol Cream
NDC Package 46708-682-01
Package Information
Docosanol cream is adults and children 12 years or over: • wash hands before and after applying cream • apply to affected area on face or lips at the first sign of cold sore/fever blister (tingle) • early treatment ensures the best results • rub in gently but completely • use 5 times a day until healed children under 12 years:ask a doctor. This formulation utilizes a cream delivery system. Marketed by Alembic Pharmaceuticals Limited, this product is identified by NDC 46708-682 and is authorized under FDA application ANDA215839.
Identification & Billing
- RxCUI: 797534 - docosanol 10 % Topical Cream
- RxCUI: 797534 - docosanol 100 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 46708 - Alembic Pharmaceuticals Limited
- 46708-682 - Docosanol
- 46708-682-01 - 1 TUBE in 1 PACKAGE / 2 g in 1 TUBE
- 46708-682 - Docosanol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (46708-682). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 46708-682-01 identifies a specific commercial package of 1 tube in 1 package / 2 g in 1 tube of Docosanol, a human over the counter drug labeled by Alembic Pharmaceuticals Limited. This cream is formulated for topical use and contains docosanol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alembic Pharmaceuticals Limited on May 08, 2025. The current certification is valid through December 31, 2026.
How is this Alembic Pharmaceuticals Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 46708068201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.